extract: 2025-11-06-trump-novo-lilly-glp1-price-deals-medicare
- Factual accuracy — The claims and new evidence appear factually correct, describing a hypothetical future scenario (2025-2026) related to GLP-1s and a "Trump Administration's November…
extract: 2025-06-01-value-in-health-comprehensive-semaglutide-medicare-economics
- Factual accuracy — The claims appear factually correct, with new evidence supporting or challenging existing claims. The added evidence provides specific quantitative data from a…
extract: 2025-03-17-norc-pace-market-assessment-for-profit-expansion
Approved (post-rebase re-approval).
extract: 2025-05-01-nejm-semaglutide-mash-phase3-liver
Here's my review of the PR:
- Factual accuracy — The new evidence regarding MASH resolution and its implications for GLP-1s appears factually correct and is supported by the cited…
extract: 2025-01-14-futardio-proposal-should-deans-list-dao-update-the-liquidity-fee-structure
Approved (post-rebase re-approval).
extract: 2025-03-17-norc-pace-market-assessment-for-profit-expansion
- Factual accuracy — The claims and entities appear factually correct based on the provided evidence.
- Intra-PR duplicates — There are no intra-PR duplicates; the new evidence is…
extract: 2025-01-01-sage-algorithmic-content-creation-systematic-review
Approved (post-rebase re-approval).
extract: 2025-01-14-futardio-proposal-should-deans-list-dao-update-the-liquidity-fee-structure
Approved.
extract: 2025-01-01-select-cost-effectiveness-analysis-obesity-cvd
- Factual accuracy — The claims and entities appear factually correct based on the provided evidence.
- Intra-PR duplicates — There are no intra-PR duplicates; the new evidence is…
extract: 2024-12-19-futardio-proposal-allocate-50000-drift-to-fund-the-drift-ai-agent-request-for
Approved (post-rebase re-approval).
extract: 2024-12-19-futardio-proposal-allocate-50000-drift-to-fund-the-drift-ai-agent-request-for
Approved.
extract: 2024-11-25-futardio-proposal-launch-a-boost-for-hnt-ore
Approved (post-rebase re-approval).
extract: 2026-01-13-aon-glp1-employer-cost-savings-cancer-reduction
Vida Domain Peer Review — PR #1059
2026-01-13-aon-glp1-employer-cost-savings-cancer-reduction
What this PR does
Enriches 4 existing GLP-1 claims with Aon's 192K-patient real-world…
extract: 2026-01-13-aon-glp1-employer-cost-savings-cancer-reduction
Vida Domain Peer Review — PR #1059
Aon GLP-1 Employer Cost Savings / Cancer Reduction Enrichments
This PR enriches five existing claims with real-world evidence from Aon's 192K-patient…